Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology crawled time : 12:01 save search
Repligen Corporation to Present at Upcoming Investor Conferences
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
RGEN | $157.495 0.23% 0.23% 290K
|
Health Technology
|
| O: -0.87%
H: 0.15%
C: -2.28%
corporation
Lumos Pharma to Participate in the Upcoming 2023 BIO International Convention and the Jefferies Healthcare Conference
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
LUMO | $2.68 3.48% 1.89% 4.7K
|
Health Technology
|
| O: 0.0%
H: 0.51%
C: -7.32%
pharma conference international
Aptose to Hold Interim Clinical Update Webcast on Saturday, June 10, 2023
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
APTO | $1.3 -4.41% -4.62% 62K
|
Health Technology
|
| O: 5.6%
H: 2.02%
C: -7.03%
update
Shockwave Medical Publishes 2022 ESG Report
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
SWAV | $328.68 -0.1% -0.1% 720K
|
Health Technology
|
| O: -0.11%
H: 0.84%
C: -0.27%
report medical esg
Prelude Therapeutics To Participate in Jefferies Healthcare Conference
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
PRLD | $3.9 4.84% 4.62% 50K
|
Health Technology
|
| O: -1.04%
H: 2.88%
C: -2.62%
conference therapeutics
Ascendis Pharma Oncology Program Update Highlights Latest Clinical Data for Product Candidates
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
ASND | $142.1 1.38% 1.39% 250K
|
Health Technology
|
| O: -0.13%
H: 2.77%
C: 1.52%
pharma update program
COMPASS Pathways’ Co-Founder Ekaterina Malievskaia to Step Down as Chief Innovation Officer
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
CMPS | $8.36 -0.24% -0.6% 360K
|
Health Technology
|
| O: -0.8%
H: 2.84%
C: -0.81%
innovation
Corvus Pharmaceuticals to Present at the Jefferies Healthcare Conference
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
CRVS | $1.44 2.86% 0.71% 130K
|
Health Technology
|
| O: 0.97%
H: 4.17%
C: -2.56%
conference pharmaceuticals
Cocrystal Pharma Receives HREC Approval to Initiate Phase 1 Study to Evaluate Oral Broad-Spectrum Coronavirus 3CL Protease Inhibitor CDI-988
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
COCP | $1.52 -0.65% -1.39% 9.7K
|
Health Technology
|
| O: 0.45%
H: 2.23%
C: -3.57%
cdi-988 pharma approval study
Aridis Receives Agreement from the FDA on a Single Confirmatory Phase 3 Study of AR-301 and the Clinical Study Design
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
ARDS | $0.0645 7.5% 2.82% 41K
|
Health Technology
|
| O: 94.59%
H: 49.86%
C: 10.39%
ar-301 fda agreement study
Transactions with Shares and Linked Securities in Genmab A/S Made By Managerial Employees and Their Closely Associated Persons
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
GNMSF | News | $289.67 1.8% 3.83% 5.3K
|
Health Technology
|
| O: -0.51%
H: 0.28%
C: 0.28%
GMAB | News | $28.97 0.94% 0.93% 450K
|
Health Technology
|
| O: -0.48%
H: 0.69%
C: 0.31%
Intra-Cellular Therapies Announces CAPLYTA Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
ITCI 4 d | $74.54 3.0% 2.96% 1.9M
|
Health Technology
|
| O: 0.81%
H: 1.82%
C: -0.88%
caplyta meeting
Celldex Announces First Patient Dosed in Phase 1 Study of CDX-585 in Patients with Advanced Malignancies
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
CLDX | $38.85 2.29% 2.19% 550K
|
Health Technology
|
| O: 0.35%
H: 4.22%
C: 1.63%
cdx-585 study
Adam Brufsky, MD, PhD, FACP Named Oncology Scientific Advisor to Myriad Genetics
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
MYGN | $18.48 -0.11% -0.11% 430K
|
Health Technology
|
| O: -0.13%
H: 1.89%
C: -0.76%
Enlivex Selected for an Elevator Pitch Presentation and two additional Poster Presentations at the 2023 Annual Meeting of the International Society for Cell & Gene Therapy
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
ENLV | News | $1.27 -3.79% -3.13% 50K
|
Health Technology
|
| O: -1.14%
H: 1.15%
C: 0.77%
presentation international cell meeting therapy
Rigel to Present at the Jefferies 2023 Global Healthcare Conference
Published: 2023-05-31 (Crawled : 12:01) - prnewswire.com
RIGL | $1.12 3.7% 3.57% 3.3M
|
Health Technology
|
| O: -1.46%
H: 5.93%
C: 3.7%
conference global
Precigen Receives FDA Clearance of IND to Initiate Phase 2 Study of PRGN-2009 Off-the-Shelf AdenoVerse Immunotherapy in Combination with Pembrolizumab to Treat Patients with Recurrent or Metastatic Cervical Cancer
Published: 2023-05-31 (Crawled : 12:01) - prnewswire.com
PGEN | $1.38 3.76% 3.62% 890K
|
Health Technology
|
| O: 0.0%
H: 2.03%
C: -3.25%
prgn-2009 fda cancer clearance immunotherapy study
Bristol Myers Squibb to Hold R&D Day on September 14
Published: 2023-05-31 (Crawled : 12:01) - biospace.com/
BMY | $49.14 0.43% 0.12% 6.4M
|
Health Technology
|
| O: -0.03%
H: 1.43%
C: 1.18%
day
Merus to Participate in a Fireside Chat at the Jefferies Healthcare Conference 2023
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
MRUS | $40.45 1.61% 1.55% 710K
|
Health Technology
|
| O: 0.62%
H: 3.89%
C: 3.04%
conference
Intercept Pharmaceuticals to Conduct One-on-One Meetings with Investors at the Jefferies Healthcare Conference June 7-8, 2023
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
ICPT | $19.0 -0.05% 4M
|
Health Technology
|
| O: -2.79%
H: 5.25%
C: 0.67%
conference pharmaceuticals
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.